Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The updated status and future direction of immunotherapy targeting B7-H1/PD-1 in osteosarcoma
Start with the recommended dose and be patient
Peptides sold in the research-chemical channel are labeled for laboratory use, are not manufactured to pharmaceutical identity or purity standards, and cannot be assumed to match the trial material in content, dose, or purity
A negligible fraction of cells were propidium iodide + alone, indicating that X(PC) does not merely initiate unprogrammed necrotic cell death in SUP-B15 cells but rather directly activates a pyroptotic lytic death through caspase activation
US$ 25.33
US$ 27.81
US$ 21.60
